Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing

Human papillomavirus (HPV) is a necessary but insufficient cause of cervical cancer. Factors influencing transcription, such as epigenetic silencing through viral DNA methylation, may impact neoplastic progression. Pyrosequencing technology was applied to quantify methylation at 19 cytosine guanine...

Full description

Saved in:
Bibliographic Details
Published inJournal of virological methods Vol. 138; no. 1; pp. 170 - 176
Main Authors Rajeevan, Mangalathu S., Swan, David C., Duncan, Kara, Lee, Daisy R., Limor, Josef R., Unger, Elizabeth R.
Format Journal Article
LanguageEnglish
Published London Elsevier B.V 01.12.2006
Amsterdam Elsevier
New York, NY
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human papillomavirus (HPV) is a necessary but insufficient cause of cervical cancer. Factors influencing transcription, such as epigenetic silencing through viral DNA methylation, may impact neoplastic progression. Pyrosequencing technology was applied to quantify methylation at 19 cytosine guanine dinucleotide (CpG) sites in the L1 3′ and long control region (LCR) of HPV 16 DNA using cell lines, CaSki (∼400 integrated copies of HPV 16) and SiHa (1–2 integrated copies of HPV 16) that differ in their transcriptional activity. Methylation levels ranged from 20 to 100% in CaSki and from 0 to 85% in SiHa over the entire 19 CpG sites, with a >40-fold difference in the methylation levels of their promoter and enhancer regions (SiHa < 2% and CaSki 79%). The method was successful at a limiting dilution of 1–4 HPV 16 DNA copies/3000 cells, a level compatible with most clinical samples. The results were not affected by fixation in methanol-based liquid cytology collection fluid or method of extraction. Conditions optimized with cell lines were applicable to fixed exfoliated cervical cells. Pyrosequencing provides a quantitative site-specific assessment of methylation at multiple CpG sites without cloning, and is thus suited to large-scale molecular epidemiologic studies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0166-0934
1879-0984
DOI:10.1016/j.jviromet.2006.08.012